159 related articles for article (PubMed ID: 38642214)
1. Multiple-matrix metabolomics analysis for the distinct detection of colorectal cancer and adenoma.
Zhang Y; Ni M; Tao Y; Shen M; Xu W; Fan M; Shan J; Cheng H
Metabolomics; 2024 Apr; 20(3):47. PubMed ID: 38642214
[TBL] [Abstract][Full Text] [Related]
2. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
3. Serum metabolite signatures in normal individuals and patients with colorectal adenoma or colorectal cancer using UPLC-MS/MS method.
Guo J; Pan Y; Chen J; Jin P; Tang S; Wang H; Su H; Wang Q; Chen C; Xiong F; Liu K; Li Y; Su M; Tang T; He Y; Sheng J
J Proteomics; 2023 Jan; 270():104741. PubMed ID: 36174955
[TBL] [Abstract][Full Text] [Related]
4. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
5. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
Di Giovanni N; Meuwis MA; Louis E; Focant JF
Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
[TBL] [Abstract][Full Text] [Related]
6. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
7. Salivary metabolomics with machine learning for colorectal cancer detection.
Kuwabara H; Katsumata K; Iwabuchi A; Udo R; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Soya R; Kaneko M; Ota S; Enomoto A; Soga T; Tomita M; Sunamura M; Tsuchida A; Sugimoto M; Nagakawa Y
Cancer Sci; 2022 Sep; 113(9):3234-3243. PubMed ID: 35754317
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
[TBL] [Abstract][Full Text] [Related]
9. Expression of miR-22 profiling in colorectal normal-adenoma-carcinoma sequence.
Li G; Zhao D; Peng X; Zhao Y
Gene; 2024 Feb; 894():147955. PubMed ID: 37925119
[TBL] [Abstract][Full Text] [Related]
10. A Preliminary Study of the Value of Plasma microRNA-193b and Soluble Urokinase-Type Plasminogen Activator Receptor in Identifying Patients with Early-Stage Colorectal Cancer and.
Liu KL; Luo JL; Wu J; Wang YD; Fan HJ
Clin Lab; 2017 Nov; 63(11):1949-1953. PubMed ID: 29226653
[TBL] [Abstract][Full Text] [Related]
11. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
12. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
[TBL] [Abstract][Full Text] [Related]
13. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
14. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer.
Kim ER; Kwon HN; Nam H; Kim JJ; Park S; Kim YH
Sci Rep; 2019 Mar; 9(1):4786. PubMed ID: 30886205
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
16. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
[TBL] [Abstract][Full Text] [Related]
18. CBX2 Expression in Colorectal Mucosa-adenoma-adenocarcinoma Sequence.
Wang B; Huang M; Wang X; Tseng Y; Luo F; Liu J
J Coll Physicians Surg Pak; 2021 Sep; 31(9):1051-1056. PubMed ID: 34500520
[TBL] [Abstract][Full Text] [Related]
19. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
20. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]